Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

A Vezzani, S Balosso, T Ravizza - Nature Reviews Neurology, 2019 - nature.com
Epilepsy is a chronic neurological disease characterized by an enduring propensity for
generation of seizures. The pathogenic processes of seizure generation and recurrence are …

[HTML][HTML] The role of inflammation in the development of epilepsy

A Rana, AE Musto - Journal of neuroinflammation, 2018 - Springer
Epilepsy, a neurological disease characterized by recurrent seizures, is often associated
with a history of previous lesions in the nervous system. Impaired regulation of the activation …

PET imaging of neuroinflammation in neurological disorders

WC Kreisl, MJ Kim, JM Coughlin, ID Henter… - The Lancet …, 2020 - thelancet.com
A growing need exists for reliable in-vivo measurement of neuroinflammation to better
characterise the inflammatory processes underlying various diseases and to inform the …

[HTML][HTML] Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E

P Ambrogini, P Torquato, D Bartolini… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Glutamate-mediated excitotoxicity, neuroinflammation, and oxidative stress are common
underlying events in neurodegeneration. This pathogenic “triad” characterizes the …

Proposal to optimize evaluation and treatment of febrile infection‐related epilepsy syndrome (FIRES): a report from FIRES workshop

S Koh, E Wirrell, A Vezzani, R Nabbout… - Epilepsia …, 2021 - Wiley Online Library
Febrile infection‐related epilepsy syndrome (FIRES) is a rare catastrophic epileptic
encephalopathy that presents suddenly in otherwise normal children and young adults …

Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies

T Ravizza, A Vezzani - Epilepsia open, 2018 - Wiley Online Library
Increasing evidence supports a pathogenic role of unabated neuroinflammation in various
central nervous system (CNS) diseases, including epilepsy. Neuroinflammation is not a …

n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis

F Frigerio, G Pasqualini, I Craparotta, S Marchini… - Brain, 2018 - academic.oup.com
Epilepsy therapy is based on drugs that treat the symptoms rather than the underlying
mechanisms of the disease (epileptogenesis). There are no treatments for preventing …

Inflammation and epilepsy: preclinical findings and potential clinical translation

G Terrone, A Salamone… - Current pharmaceutical …, 2017 - ingentaconnect.com
Background: The lack of treatments which can prevent epilepsy development or improve
disease prognosis represents an unmet and urgent clinical need. The development of such …

[HTML][HTML] Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target

I Mukhtar - Seizure, 2020 - Elsevier
Epilepsy is a brain disease associated with epileptic seizures as well as with
neurobehavioral outcomes of this condition. In the last century, inflammation emerged as a …